Type II variation for application SFDA-2023-0057. Type II variation: Container Closure Change for Neuravastatin — routine update

Variation Number
SFDA-2023-0057-V457
Type
Type II
Application
Status
Approved
Fee
€45,216
Submitted
—
Approved
2024-07-18
Description

Type II variation: Container Closure Change for Neuravastatin — routine update